Patent · US Expired

Immunoenzymatic method in homogeneous phase for the determination of anti-plasmodium falciparum-sporozoite antibodies in human blood

US5210018A · kind A · utility

4Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 1989
Grant dateMay 11, 1993
Priority date
Expiry dateApr 20, 2009

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An immunoenzymatic method for the detection of anti-Plasmodium falciparum-sporozoite antibodies in a sample of human blood, which operates, in homogeneous phase, and under suitable conditions, with a synthetic polypeptidic antigen (P), a synthetic antigen-enzyme (P-E) conjugate, wherein said antigen is capable of specifically reacting with the anti-Plasmodium falciparum-sporozoite antibodies (Ab) possibly present in the sample, and an inert substance capable of quantitatively precipitating the antibody-synthetic antigen-enzyme complex (Ab-P-E). The method, due to its specificity, sensitivity, reproducibility and rapidity, is particularly useful in the epidemiological investigations into malaria and in the evaluation of the efficacy of an antimalarial vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.